Hard to judge what is going on behind the scenes
They need $50m or so in 2024 to get to production before this CR and or Equity deal etc
This TH and Suspension has occurred relatively quick after quarterly release which indicated under 2 quarters of cash remain and cash burn explosion etc
With a balance sheet like that - they were not going to attract interest and IDC would not loan when interest quarterly in arrears would need to be paid and or to pay running costs with funds - using vita construction dollars
Difficult to see production this year as construction unknowns always have to be factored in with time frames - haven't even started and we are already in March
IMO - to get this to production some of the 85% will have to be foregone - the risks are still high and imo TSP will settle further in 2024
Lets see the details of the CR is next week - the length of this suspension is not a good sign
Chuk has told us all there is no options attached in this CR -so we take his word on this from a dilution point of view
IMO
- Forums
- ASX - By Stock
- MNB
- Ann: Suspension from Quotation
Ann: Suspension from Quotation, page-172
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNB (ASX) to my watchlist
|
|||||
Last
7.1¢ |
Change
0.001(1.43%) |
Mkt cap ! $62.38M |
Open | High | Low | Value | Volume |
7.0¢ | 7.3¢ | 7.0¢ | $192.2K | 2.700M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 58156 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 49933 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 58156 | 0.071 |
2 | 97150 | 0.070 |
4 | 225652 | 0.069 |
2 | 93000 | 0.068 |
1 | 14925 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.072 | 49933 | 1 |
0.073 | 90000 | 2 |
0.074 | 141000 | 2 |
0.075 | 400000 | 2 |
0.077 | 84341 | 2 |
Last trade - 15.50pm 13/08/2024 (20 minute delay) ? |
Featured News
MNB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online